Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Turnaround Potential
1304.4000
-9.80
(
-0.75
%)
NSE
Mar 30, 2026
15:31 PM
New 52W High in past week
Volume:
2.5M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
07 Nov 2025
1304.40
-0.75%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1345 | Upside : 3.1%
Target
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
Motilal Oswal increased Buy price target of Aurobindo Pharma Ltd. to 1500.0 on 23 Mar, 2026.
More from Aurobindo Pharma Ltd.
Recommended
Five stocks to buy from analysts this week - March 31, 2026
The Baseline |
31 Mar 2026, 06:14PM
IPOs queue up despite recent muted debuts
|
30 Mar 2026, 05:19PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020